Skip to content

Teleflex TFX Restructuring Charges

Restructuring Charges at other companies

Boston Scientific logo
Boston ScientificBSX
$3M-70.0%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$32M+88.2%
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$548.3M+32.3%
Gross profit$307.4M+20.4%
Operating income$20.2M-73.4%
Net income-$8.2M-109%
EPS (diluted)-$0.18-109%

Balance sheet

See full
Cash & equivalents$329.6M+16.8%
Total debt$2.8B+38.6%
Total equity$3.1B-24.7%
Total assets$6.8B-5.3%

Cash flow

See full
Operating cash flow$46.7M+68.3%
CapEx$18.8M-22.1%
Free cash flow$27.9M+676%

Valuation

See full
Market cap$5.62B-14.4%
Enterprise value$8.07B-2.0%
P/S2.6×-1.2×

Profitability

See full
Gross margin38.2%-3.0pp
Operating margin3%-11.8pp
Net margin-47.4%-56.2pp
FCF margin7.9%

Returns & leverage

See full
Return on equity-28.1%-31.6pp
Debt / equity0.9×+0.4×
Current ratio2.6×+0.3×

Where this comes from

Reported directly by Teleflex in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCharges.

The official record: Teleflex’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Teleflex's restructuring charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Teleflex's restructuring charges?
Teleflex (TFX) reported restructuring charges of $16.85M in Q1 2026.
How has Teleflex's restructuring charges changed year-over-year?
Teleflex's restructuring charges increased by 1084.6% year-over-year, from $1.42M to $16.85M.
What does restructuring charges mean?
One-time costs from reorganizing operations, including employee severance, facility closure costs, contract termination fees, and asset relocation expenses.